I'm not so sure. It will be interesting to see the 4E due out in a couple of weeks.
I think that the company was going great guns post the Medivet Disaster and we started to see some good cash generation but what we do not know is what has been the impact of the loss of Carefusion OEM contract. Previous management always trumpeted how great this was - has this loss wiped out the good work done else where? At the half year they had generated $250k NP, By the sounds of it they they will be lucky go anywhere near that in the second half. Probably more important is what will it mean for 2018 - I don't imagine that business like that is easy to come by.
In the commentaries in previous announcements there was always talk of possible acquisitions. With the loss of Carefusion I'm guessing that will put pressure on cash so how do they do anything - further capital raisings and further dilution? Maybe, just maybe the ICU offer is the best way forward. IMHO
MLA Price at posting:
8.3¢ Sentiment: Hold Disclosure: Held
